Literature DB >> 18208539

Transcription factor early growth response-1 induction mediates inflammatory gene expression and brain damage following transient focal ischemia.

Kudret Tureyen1, Nathaniel Brooks, Kellie Bowen, John Svaren, Raghu Vemuganti.   

Abstract

Early growth response-1 (Egr1) is a sequence-specific transcription factor (TF) which is induced under hypoxic conditions. We presently report that transient middle cerebral artery occlusion (MCAO) leads to increased expression of Egr1 in the brains of adult mice and rats between 2 h and 5 days of reperfusion with a peak increase of 8-12-fold at 1 day. When subjected to transient MCAO and 3 days of reperfusion, Egr1-/- mice showed significantly smaller infarcts (by 44.9 +/- 8.4%, p < 0.05) and improved neurological function than Egr1+/+ littermates. Following transient MCAO, brains of Egr1-/- mice showed less water accumulation and decreased neutrophil infiltration (by 42 +/- 8%, p < 0.05) compared to Egr1+/+ mice. The number of activated microglia/macrophages were also significantly lower (OX42+ cells by 53 +/- 9%, p < 0.05 and ED1+ cells by 59 +/- 11%) in the post-ischemic cortex of Egr1-/- mice compared to Egr1+/+ mice. In addition, post-ischemic inflammatory gene expression was less pronounced in the brains of Egr1-/- mice compared to Egr1+/+ mice. Preventing cerebral Egr1 protein induction with small interference RNAs that target Egr1 decreased inflammatory gene expression and led to smaller infarcts (by 40.2 +/- 6.9%, p < 0.05) and reduced neurological deficits in rats subjected to transient MCAO. Conversely, transient MCAO following adenoviral-mediated Egr1 over-expression exacerbated the infarct volume (by 29 +/- 5.3%, p < 0.05) and worsened the neurological deficits in rats. These studies indicate Egr1 as a significant contributor of inflammation and neuronal damage after stroke.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18208539      PMCID: PMC2603292          DOI: 10.1111/j.1471-4159.2008.05233.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  39 in total

1.  Parallel gene expression monitoring using oligonucleotide probe arrays of multiple transcripts with an animal model of focal ischemia.

Authors:  M A Soriano; M Tessier; U Certa; R Gill
Journal:  J Cereb Blood Flow Metab       Date:  2000-07       Impact factor: 6.200

2.  Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain.

Authors:  M Bergeron; A Y Yu; K E Solway; G L Semenza; F R Sharp
Journal:  Eur J Neurosci       Date:  1999-12       Impact factor: 3.386

3.  Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats.

Authors:  Eduardo Candelario-Jalil; Armando González-Falcón; Michel García-Cabrera; Olga Sonia León; Bernd L Fiebich
Journal:  J Neurochem       Date:  2006-12-20       Impact factor: 5.372

4.  Decreased brain damage and curtailed inflammation in transcription factor CCAAT/enhancer binding protein beta knockout mice following transient focal cerebral ischemia.

Authors:  Ramya Kapadia; Kudret Tureyen; Kellie K Bowen; Haviryaji Kalluri; Peter F Johnson; Raghu Vemuganti
Journal:  J Neurochem       Date:  2006-08-08       Impact factor: 5.372

5.  Monocyte chemoattractant protein-1 plays a critical role in neuroblast migration after focal cerebral ischemia.

Authors:  Yi-Ping Yan; Kurt A Sailor; Bradley T Lang; Seung-Won Park; Raghu Vemuganti; Robert J Dempsey
Journal:  J Cereb Blood Flow Metab       Date:  2006-12-27       Impact factor: 6.200

6.  JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia.

Authors:  Irawan Satriotomo; Kellie K Bowen; Raghu Vemuganti
Journal:  J Neurochem       Date:  2006-09       Impact factor: 5.372

7.  Transcription factor nuclear factor-kappa B is activated in neurons after focal cerebral ischemia.

Authors:  D Stephenson; T Yin; E B Smalstig; M A Hsu; J Panetta; S Little; J Clemens
Journal:  J Cereb Blood Flow Metab       Date:  2000-03       Impact factor: 6.200

8.  Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.

Authors:  Kudret Tureyen; Ramya Kapadia; Kellie K Bowen; Irawan Satriotomo; Jin Liang; Douglas L Feinstein; Raghu Vemuganti
Journal:  J Neurochem       Date:  2007-04       Impact factor: 5.372

9.  Therapeutic effects of hyperbaric oxygen in a rat model of endothelin-1-induced focal cerebral ischemia.

Authors:  Zhen-Xing Huang; Zhi-Min Kang; Guo-Jun Gu; Guang-Neng Peng; Liu Yun; Heng-Yi Tao; Wei-Gang Xu; Xue-Jun Sun; John H Zhang
Journal:  Brain Res       Date:  2007-03-28       Impact factor: 3.252

Review 10.  Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage.

Authors:  Jae-Hyuk Yi; Seung-Won Park; Ramya Kapadia; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2007-05-03       Impact factor: 3.921

View more
  27 in total

Review 1.  Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy.

Authors:  Swati Bhattacharyya; Minghua Wu; Feng Fang; Warren Tourtellotte; Carol Feghali-Bostwick; John Varga
Journal:  Matrix Biol       Date:  2011-04-13       Impact factor: 11.583

2.  Paradoxical exacerbation of neuronal injury in reperfused stroke despite improved blood flow and reduced inflammation in early growth response-1 gene-deleted mice.

Authors:  Andrew F Ducruet; Sergey A Sosunov; Scott H Visovatti; Danica Petrovic-Djergovic; William J Mack; E Sander Connolly; David J Pinsky
Journal:  Neurol Res       Date:  2011-09       Impact factor: 2.448

Review 3.  All's well that transcribes well: non-coding RNAs and post-stroke brain damage.

Authors:  Raghu Vemuganti
Journal:  Neurochem Int       Date:  2013-08-15       Impact factor: 3.921

4.  Altered expression of PIWI RNA in the rat brain after transient focal ischemia.

Authors:  Ashutosh Dharap; Venkata Prasuja Nakka; Raghu Vemuganti
Journal:  Stroke       Date:  2011-02-10       Impact factor: 7.914

5.  Exacerbated brain damage, edema and inflammation in type-2 diabetic mice subjected to focal ischemia.

Authors:  Kudret Tureyen; Kellie Bowen; Jin Liang; Robert J Dempsey; Raghu Vemuganti
Journal:  J Neurochem       Date:  2011-01-25       Impact factor: 5.372

6.  Egr-1 transactivates Bim gene expression to promote neuronal apoptosis.

Authors:  Bo Xie; Chong Wang; Zhihao Zheng; Bin Song; Chi Ma; Gerald Thiel; Mingtao Li
Journal:  J Neurosci       Date:  2011-03-30       Impact factor: 6.167

7.  Increased cerebral protein ISGylation after focal ischemia is neuroprotective.

Authors:  Venkata P Nakka; Bradley T Lang; Deborah J Lenschow; Dong-Er Zhang; Robert J Dempsey; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2011-08-17       Impact factor: 6.200

8.  Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome.

Authors:  Ashuthosh Dharap; Kellie Bowen; Robert Place; Long-Cheng Li; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2009-01-14       Impact factor: 6.200

9.  Neutrophil elastase and neurovascular injury following focal stroke and reperfusion.

Authors:  Ann M Stowe; Tracy L Adair-Kirk; Ernesto R Gonzales; Ronald S Perez; Aarti R Shah; Tae S Park; Jeffrey M Gidday
Journal:  Neurobiol Dis       Date:  2009-04-22       Impact factor: 5.996

10.  PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.

Authors:  Jae-Hyuk Yi; Seung-Won Park; Nathaniel Brooks; Bradley T Lang; Raghu Vemuganti
Journal:  Brain Res       Date:  2008-10-09       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.